Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial
Cahn, Pedro, Andrade-Villanueva, Jaime, Arribas, José R, Gatell, José M, Lama, Javier R, Norton, Michael, Patterson, Patricia, Madero, Juan Sierra, Sued, Omar, Figueroa, Maria Inés, Rolon, Maria JoséТом:
14
Мова:
english
Журнал:
The Lancet Infectious Diseases
DOI:
10.1016/S1473-3099(14)70736-4
Date:
July, 2014
Файл:
PDF, 321 KB
english, 2014
File converter
Більше результатів пошуку
More benefits 
